Delivery Order SPE2DB20D2001-SPE2DB25FPNVM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a $19,456.34 delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed price arrangement. This competitively awarded, non-set-aside contract is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's distribution center in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 6, 2025, and represents a delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120 count units) valued at $9,728.17, with an ultimate completion date of June 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract valued at $9.7K. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,728.17 to supply Venclexta 100 mg tablets (120-count units) with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on September 10, 2025, with completion targeted for October 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (28-count units) valued at $2,289.70. The contract, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a firm fixed-price, non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $2,289.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Venclexta 100 mg tablets (28-count unit dosage). This non-set-aside competitive award is scheduled for completion by September 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNVMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets in a quantity of 28 units, valued at $6,869.10. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 20, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1.0 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support to military healthcare systems globally. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical federal vendor supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Venclexta—a oncology medication—represents a routine pharmaceutical procurement supporting military medical supply chain requirements. The award demonstrates the contractor's established capability to meet federal procurement standards through open competition and its integral role in sustaining pharmaceutical availability for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/26/25 |